InsideArbitrage February 2025 Mid-Month Update – Portfolio Updates

Feb 15, 2025

∙ Paid

Instead of discussing a new idea for our February mid-month update, I figured I would briefly touch on five different situations, four of which are in the model portfolio and one is an interesting merger arbitrage situation with a hostile bid.

1. Avadel Pharmaceuticals (AVDL): $8.61

Market Cap: $866.29M

Enterprise Value: $838.74M

We discussed Avadel Pharmac…

Keep reading with a 7-day free trial

Subscribe to The Special Situation Report to keep reading this post and get 7 days of free access to the full post archives.